[1]
M. E. Nyeland, L. Becia, D. S. Patel, K. A. Veverka, and A. R. Swensen, “Calcipotriene plus betamethasone dipropionate (0.005%/0.064%) foam and apremilast: matching-adjusted indirect comparison and US cost per responder analyses”, J of Skin, vol. 2, p. S91, Dec. 2018.